Colesevelam attenuates cholestatic liver and bile duct injury in <i>Mdr2<sup>−/−</sup> </i> mice by modulating composition, signalling and excretion of faecal bile acids
Claudia Fuchs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Nadja Leditznig(Medical University of Vienna), Annika Wahlström(University of Gothenburg), Emina Halilbasic(Medical University of Vienna), Andrea Thüringer(Medical University of Graz), Victoria Kunczer(Medical University of Vienna), Veronika Mlitz(Medical University of Vienna), Hanns–Ulrich Marschall(University of Padua), G. Paumgartner, Tatjana Stojaković, Marcus Ståhlman(University of Gothenburg), Karl Kashofer(Medical University of Graz)
Cited by 76
Related Papers
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k